Valérie Cuvier

Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results

Dan Atar, Håkan Arheden, Alain Berdeaux et al. · European Heart Journal · 2014 · 189 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis

Timothée Lenglet, Lucette Lacomblez, Jean‐Louis Abitbol et al. · European Journal of Neurology · 2014 · 128 citations

Medicine, Neurology, Pharmacotherapy +17

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial

Bruno François, Simon Lambden, Tom Fivez et al. · The Lancet Respiratory Medicine · 2023 · 74 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +11

Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial

Bruno François, Xavier Wittebole, Ricard Ferrer et al. · Intensive Care Medicine · 2020 · 71 citations · Full text

Veterinary Medicine, Infectious Diseases, Inflammation +6

A first‐in‐man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM‐1 receptor inhibition

Valérie Cuvier, Ulrike Lorch, Stephan Witte et al. · British Journal of Clinical Pharmacology · 2018 · 44 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15